308 related articles for article (PubMed ID: 15247216)
1. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
2. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
Mercado PA; Ayala YM; Romano M; Buratti E; Baralle FE
Nucleic Acids Res; 2005; 33(18):6000-10. PubMed ID: 16254078
[TBL] [Abstract][Full Text] [Related]
3. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
4. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
5. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
6. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
7. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
[TBL] [Abstract][Full Text] [Related]
8. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
9. Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA.
Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Biochem Biophys Res Commun; 2018 Nov; 506(3):703-708. PubMed ID: 30376989
[TBL] [Abstract][Full Text] [Related]
10. Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNA.
Selvakumar M; Helfman DM
RNA; 1999 Mar; 5(3):378-94. PubMed ID: 10094307
[TBL] [Abstract][Full Text] [Related]
11. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding.
Lavigueur A; La Branche H; Kornblihtt AR; Chabot B
Genes Dev; 1993 Dec; 7(12A):2405-17. PubMed ID: 8253386
[TBL] [Abstract][Full Text] [Related]
12. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
13. Factors involved in the activation of pre-mRNA splicing from downstream splicing enhancers.
Achsel T; Shimura Y
J Biochem; 1996 Jul; 120(1):53-60. PubMed ID: 8864844
[TBL] [Abstract][Full Text] [Related]
14. An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.
McCullough AJ; Berget SM
Mol Cell Biol; 2000 Dec; 20(24):9225-35. PubMed ID: 11094074
[TBL] [Abstract][Full Text] [Related]
15. Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers.
Ibrahim EC; Schaal TD; Hertel KJ; Reed R; Maniatis T
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5002-7. PubMed ID: 15753297
[TBL] [Abstract][Full Text] [Related]
16. Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene.
Tran VK; Takeshima Y; Zhang Z; Yagi M; Nishiyama A; Habara Y; Matsuo M
J Med Genet; 2006 Dec; 43(12):924-30. PubMed ID: 16738009
[TBL] [Abstract][Full Text] [Related]
17. Computational analysis of splicing errors and mutations in human transcripts.
Kurmangaliyev YZ; Gelfand MS
BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
[TBL] [Abstract][Full Text] [Related]
18. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
[TBL] [Abstract][Full Text] [Related]
19. Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
Nielsen KB; Sørensen S; Cartegni L; Corydon TJ; Doktor TK; Schroeder LD; Reinert LS; Elpeleg O; Krainer AR; Gregersen N; Kjems J; Andresen BS
Am J Hum Genet; 2007 Mar; 80(3):416-32. PubMed ID: 17273963
[TBL] [Abstract][Full Text] [Related]
20. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
